2024 Global Summit to recognize oncology innovators and groundbreaking work – AIM-HI Accelerator Fund

AIM-HI Accelerator Fund posted the following on LinkedIn:

“The 2024 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, co-hosted by AIM-HI partnering with the National Foundation for Cancer Research (NFCR), is set for October 18, 2024, at the National Press Club in Washington, DC. Join us to celebrate innovators of the oncology field and recognize the relentless dedication and groundbreaking work of translating scientific discoveries into effective treatments that improve the lives of patients worldwide.

Register and support today at: https://bit.ly/3ywm0gc

The conference consists of four parts:

1. New Frontier for Cancer Research, including a morning keynote address from Dr. Drew Pardoll and two panels: New Approaches to Cancer Treatments and Early Detection & Cancer Prevention;
2. Luncheon & AIM-HI Women’s Initiatives Award Ceremony, honoring AACR CEO Dr. Margaret Foti, who will receive the 2024 Beacon Award for Women Leaders in Oncology; the 2024 Women’s Venture Competition winners Nabanita Nawar, PhD, of HDAX Therapeutics and Paraskevi (Evi) Giannakakou, Ph.D. of ARMA BIO;
3. Emerging Oncology Companies Showcase and Investors’ Perspective, moderated by Matt Tremblay, Ph.D., Chairman of the AIM-HI Board of Directors and CEO of Blackbird Laboratories.
4. Reception, Dinner & 2024 Szent-Györgyi Prize Award Ceremony honoring Dr. Dennis J. Slamon with UCLA, with an evening keynote address from Dr. Siddhartha Mukherjee, 2011 Pulitzer Prize Winner.

Find out the full program details and other high-profile speakers at this exciting event here.”

Source: AIM-HI Accelerator Fund/LinkedIn